CWA
EDIT icon

Capital Wealth Alliance’s Editas Medicine EDIT Stock Holding History

Capital Wealth Alliance’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-70
Closed -$2K – 146
2019
Q4 		$2K Buy
+70
New +$1.75K ﹤0.01% 304

Other funds holding EDIT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Capital Wealth Alliance's EDIT Position: Q1 2020 in Review

Capital Wealth Alliance sold out of Editas Medicine (EDIT) in Q1 2020, closing a stake of 70 shares — an estimated $2K sold.

Capital Wealth Alliance first reported a position in EDIT in Q4 2019 and held it in 1 quarter. The position peaked at $2K in Q4 2019. 199 funds tracked by Wall St. Rank hold EDIT as of Q1 2020.

  • Capital Wealth Alliance reported no remaining Editas Medicine position as of Q1 2020 after selling out during the quarter.
  • Capital Wealth Alliance sold 70 Editas Medicine shares in Q1 2020, an estimated $2K.
  • Capital Wealth Alliance first reported a position in Editas Medicine in Q4 2019 and held it in 1 quarter.
  • Capital Wealth Alliance's Editas Medicine position peaked at $2K in Q4 2019.
  • 199 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2020.

Based on Capital Wealth Alliance's 13F filing for Q1 2020, filed 28 Apr 2020.